MiMedx (NSDQ:MDXG) said today that it filed an IND application with the FDA for the company’s late-stage Achilles tendonitis trial.
The 158-patient study is designed to compare MiMedx’s AmnioFix Injectable with a saline placebo injection in the treatment of moderate to severe pain due to Achilles tendonitis.
Get the full story at our sister site, Drug Delivery Business News.
The post MiMedx files IND for Achilles tendonitis trial appeared first on MassDevice.
from MassDevice http://ift.tt/2wAUqc1
Cap comentari:
Publica un comentari a l'entrada